Columbia-based Martek Biosciences receives $81.4M from stock sale

Daily Record, The (Baltimore), Jan 27, 2005 by Staff

Martek Biosciences Corp., of Columbia, which develops, manufactures and sells products from microalgae, said yesterday it received approximately $81.4 million after completing the sale of more than 1.7 million shares of common stock at a public offering price of $49.10 per share. Martek said it will use the proceeds for capital expenditures, working capital and general corporate purposes.

Copyright 2005 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with ProQuest

Most Recent Business Articles

Most Recent Business Publications

Most Popular Business Articles

Most Popular Business Publications